The Lack of Predictors for Rapid Progression in Prostate Cancer Patients Receiving Sipuleucel-T

By Ng Laura   Heck Wendy   Lavsa Stacey   Crowther David   Atkinson Brad   Xiao Lianchun   Araujo John  

Cancers, Vol. 5, Iss. 2, 2013-05 ,pp. : 511-518

MDPI

Access to resources Recommend Favorite

Immunotherapy and Immune Evasion in Prostate Cancer

By Thakur Archana   Vaishampayan Ulka   Lum Lawrence G.  

Cancers, Vol. 5, Iss. 2, 2013-05 ,pp. : 569-590

MDPI

Access to resources Recommend Favorite

Therapeutic Cancer Vaccines in Prostate Cancer: The Quest for Intermediate Markers of Response

By Kim Joseph W.   Bilusic Marijo   Heery Christopher J.   Madan Ravi A.  

Cancers, Vol. 4, Iss. 4, 2012-11 ,pp. : 1229-1246

MDPI

Access to resources Recommend Favorite

Natural Killer T Cells Subsets in Cancer, Functional Defects in Prostate Cancer and Implications for Immunotherapy

By Nowak Michael   Schmidt-Wolf Ingo G.H.  

Cancers, Vol. 3, Iss. 3, 2011-09 ,pp. : 3661-3675

MDPI

Access to resources Recommend Favorite

Cancer-Associated Fibroblasts Modify the Response of Prostate Cancer Cells to Androgen and Anti-Androgens in Three-Dimensional Spheroid Culture

By Eder Theresa   Weber Anja   Neuwirt Hannes   Grünbacher Georg   Ploner Christian   Klocker Helmut   Sampson Natalie   Eder Iris E.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1458-1458

MDPI

Access to resources Recommend Favorite